Abstract

There is a rising interest in the use of dietary interventions to ameliorate prevalent brain diseases, including Autism Spectrum Disorder (ASD). Nowadays, the existence of communication between gut and brain is well accepted and thus diet can influence brain functioning. A well-known nutrition based intervention for ASD is the gluten-free and casein-free diet. However, only some of the patients experience a relief in symptoms and thus efficacy seems to be limited to certain phenotypes. However, not much is known about the mechanism of action through which this diet might work, or about interpersonal differences that could lead to variation in response to the diet. Current evidence for efficacy of the GFCF diet is poor. Large scale, good quality randomized controlled trials are needed. Genetic and environmentally induced interpersonal differences were found in intestinal membrane permeability and blood brain barrier integrity as well as in activity of peptidase enzymes. These differences probably affect responsiveness to the diet. In addition, age and duration of the dietary intervention play a role in the efficacy of the gluten-free and casein-free diet. This is the reason why all these factors need to be taken into account to give appropriate advice about whether or not to follow this diet.

Highlights

  • A growing number of children are diagnosed with Autism Spectrum Disorder (ASD), a category of neuro developmental disorders such as Autism, Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) and Asperger’s disorder, collectively included in the DSM-V criteria

  • Other individual differences that modulate the response to the GFCF diet include an increased intestinal permeability, which is seen in a substantial proportion of children with ASD, a more permeable Blood Brain Barrier (BBB) and a decreased DPP4 enzyme activity [74]

  • Several factors were found to influence the individual responsiveness to the GFCF dietary intervention in ASD patients

Read more

Summary

Introduction

A growing number of children are diagnosed with Autism Spectrum Disorder (ASD), a category of neuro developmental disorders such as Autism, Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) and Asperger’s disorder, collectively included in the DSM-V criteria. The prevalence of ASD is at least 1 in 160 children worldwide [2,3,4]. It is called a spectrum disorder because patients show a varying degree and severity of symptoms [1]. Prenatal and perinatal environmental exposures (e.g., dietary factors, maternal diabetes, stress, medications, or infections and certainly those that require antibiotic use) are associated with an increased risk of ASD [2,10]. There is an increased prevalence of immune-mediated disorders in family members of children with ASD, including rhinitis, food allergy, and psoriasis and possibly even inflammatory bowel disease [10,14,15]

GFCF Diet in ASD
Gut Microbiota Dysbiosis in ASD
The Microbiome in ASD
Microbiota Dysbiosis in ASD
Relevance of blood transport
Immune system in ASD
The ENS and Nervus Vagus in ASD
Gluten and Casein Proteins Affect the Brain via the Bloodstream
Excessive Opioid Activity in Patients with Autism Spectrum Disorder
Short and long term GFCF intervention studies
Different individual GFCF diet responsiveness
Risks associated with GFCF diets in ASD patients
Altered intestinal permeability in people with autism spectrum disorder
Blood brain barrier integrity in people with autism spectrum disorder
Urinary peptide analysis in ASD
Critical Appraisal
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call